Maravai LifeSciences Holdings Inc. Class A Common Stock vs Public Storage — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while Public Storage trades at $290.77 (market cap $53.89B). The key difference: Public Storage is far larger — about 55.4× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Public Storage pays a 4.16% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Public Storage for 130 Days on average.
| MRVI | PSA | |
|---|---|---|
Market Cap | $972.90M | $53.89B |
Volume | 4,325,710 | 947,047 |
Sector | Health | Real Estate |
52-Week High | $9.00 | $330.47 |
52-Week Low | $2.83 | $258.44 |
Typical Hold Time | 0 Days | 130 Days |
Enterprise Value | $1.08B | $68.16B |
Dividend Yield | — | 4.16% |
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Public Storage (PSA) trades at $288.76, showing minimal daily movement (-0.04%) with neutral technical indicators. The REIT maintains strong fundamentals including a 41.8% net income margin and consistent earnings beats, though valuation metrics appear elevated with a P/E of 27.52. Recent developments include the completion of the Public Storage Canada acquisition and a $400 million Canadian debt offering, positioning for strategic growth.
PSA presents a mixed outlook with analyst consensus pointing to 14% upside to the $328.33 price target, though the majority (64%) recommend Hold. Key risks include REIT sector sensitivity to interest rates and competitive pressures, while the 4.05% dividend yield provides income stability. The stock's premium valuation requires sustained operational execution to justify further gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →Public Storage is the largest owner of self-storage facilities in the U.S. with more than 2,800 self-storage facilities in 39 states and approximately 200 million square feet of rentable space. Through equity interests, it also has exposure to the European self-storage market through Shurgard Self Storage and to an additional 28 million net rentable square feet of industrial space in the United States through PS Business Parks.
Read more on PSA →